"Tule turvallisesti paikan päälle tai asioi etänä. Varaa aika verkkosivuiltamme tai asiakaspalvelun kautta numerosta 030 6000. Ajanvaraus on auki vuorokauden ympäri. Koko Suomen kattavaa toimipaikkaverkostoa täydentävät ympäri vuorokauden saatavilla olevat digitaaliset etäpalvelut. Lääkäri-chat päivystää ilman ajanvarausta 24/7. Voit myös varata ajan video- tai puhelinvastaanotolle valitsemallesi asiantuntijalle. Nopeasti hyvään hoitoon!"

During the past decade, Terveystalo Oulu conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Terveystalo Oulu" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Bayer" with 2 trials sponsored, "Biohit Oyj" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Terveystalo Oulu" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "The Finnish Funding Agency for Technology and Innovation (TEKES)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Terveystalo Oulu" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Chronic Kidney Disease" (1 trials), "Cluster Headache" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Terveystalo Oulu" in a lesser frequency.

Most popular intervention types in "Terveystalo Oulu" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Acetium" (2 trials), "bococizumab (PF-04950615)" (2 trials), "linagliptin" (2 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Terveystalo Oulu" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Terveystalo Oulu". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Terveystalo Oulu, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Terveystalo Oulu, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".